Editorial: Harnessing the potential of FLASH: questions we must address prior to effective clinical translation

Per Rugaard Poulsen, Kevin M Prise, Ranald I MacKay

Research output: Contribution to journal › Editorial › peer-review

2 Downloads (Pure)

Keywords

Editorial: Harnessing the potential of FLASH: questions we must address prior to effective clinical translation
Copyright 2024 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
Final published version, 237 KBLicence: CC BY

@article{0b4d91573f31457d94ac32e512311775,

title = "Editorial: Harnessing the potential of FLASH: questions we must address prior to effective clinical translation",

keywords = "clinical translation, ultra-high dose rate, radiation oncology, radiotherapy, FLASH",

author = "Poulsen, {Per Rugaard} and Prise, {Kevin M} and MacKay, {Ranald I}",

year = "2024",

month = nov,

day = "13",

doi = "10.3389/fonc.2024.1515325",

language = "English",

volume = "14",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial: Harnessing the potential of FLASH: questions we must address prior to effective clinical translation

AU - Poulsen, Per Rugaard

AU - Prise, Kevin M

AU - MacKay, Ranald I

PY - 2024/11/13

Y1 - 2024/11/13

KW - clinical translation

KW - ultra-high dose rate

KW - radiation oncology

KW - radiotherapy

KW - FLASH

U2 - 10.3389/fonc.2024.1515325

DO - 10.3389/fonc.2024.1515325

M3 - Editorial

C2 - 39605893

SN - 2234-943X

VL - 14

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1515325

ER -